Literature DB >> 21613825

FoxO family members in cancer.

Yuqing Zhang1, Boyi Gan, Debra Liu, Ji-hye Paik.   

Abstract

The PI3K-Akt-FoxO signaling pathway plays a central role in diverse physiological processes including cellular energy storage, growth, and survival, among others. As an important effector of this pathway, FoxO is involved in versatile activities that protect organisms from stress and aging. Recent studies on mammalian FoxO have established a direct role for this transcription factor family in cellular proliferation, oxidative stress response, and tumorigenesis. The review will focus on the recent developments pertaining to the function of FoxO as well as discuss the various contexts in which FoxO exerts distinct biological activity such as drug resistance and autophagy in cancer pathogenesis and therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613825     DOI: 10.4161/cbt.12.4.15954

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  78 in total

Review 1.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

2.  FOXO3a and β-catenin co-localization: double trouble in colon cancer?

Authors:  Yibing Yan; Mark R Lackner
Journal:  Nat Med       Date:  2012-06-06       Impact factor: 53.440

3.  Spatiotemporal expression of foxo4, foxo6a, and foxo6b in the developing brain and retina are transcriptionally regulated by PI3K signaling in zebrafish.

Authors:  Sheng-Jia Lin; Ming-Chang Chiang; Hung-Yu Shih; Kun-Chun Chiang; Yi-Chuan Cheng
Journal:  Dev Genes Evol       Date:  2017-02-02       Impact factor: 0.900

4.  Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.

Authors:  Bolag Altan; Takehiko Yokobori; Munenori Ide; Erito Mochiki; Yoshitaka Toyomasu; Norimichi Kogure; Akiharu Kimura; Keigo Hara; Tuya Bai; Pinjie Bao; Masaki Suzuki; Kyoichi Ogata; Takayuki Asao; Masahiko Nishiyama; Tetsunari Oyama; Hiroyuki Kuwano
Journal:  Gastric Cancer       Date:  2015-10-15       Impact factor: 7.370

5.  FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.

Authors:  Aifu Lin; Hai-Long Piao; Li Zhuang; Dos D Sarbassov; Li Ma; Boyi Gan
Journal:  Cancer Res       Date:  2014-01-21       Impact factor: 12.701

Review 6.  Mitochondrial and postmitochondrial survival signaling in cancer.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Mitochondrion       Date:  2013-12-10       Impact factor: 4.160

7.  Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Qinlong Li; Peizhen Hu; Changhong Shi; Yang Li; Yi-Ting Chen; Fei Yin; Chun-Peng Liao; Bangyan L Stiles; Haiyen E Zhau; Jean C Shih; Leland W K Chung
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

Review 8.  FoxO transcription factors in cancer metabolism.

Authors:  Raj Kumar Yadav; Anoop Singh Chauhan; Li Zhuang; Boyi Gan
Journal:  Semin Cancer Biol       Date:  2018-01-05       Impact factor: 15.707

Review 9.  Genome-wide identification and characterization of Fox genes in the silkworm, Bombyx mori.

Authors:  JiangBo Song; ZhiQuan Li; XiaoLing Tong; Cong Chen; Min Chen; Gang Meng; Peng Chen; ChunLin Li; YaQun Xin; TingTing Gai; FangYin Dai; Cheng Lu
Journal:  Funct Integr Genomics       Date:  2015-04-17       Impact factor: 3.410

10.  AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival.

Authors:  Emilio Cosimo; Anuradha Tarafdar; Michael W Moles; Ailsa K Holroyd; Natasha Malik; Mark A Catherwood; Jodie Hay; Karen M Dunn; Alan M Macdonald; Sylvie M Guichard; Declan O'Rourke; Michael T Leach; Owen J Sansom; Sabina C Cosulich; Alison M McCaig; Alison M Michie
Journal:  Clin Cancer Res       Date:  2018-12-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.